Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculation
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing cases of cancer and chronic diseases
3.2.1.2 Advancements in cell culture technologies
3.2.1.3 Rising investments in biotechnology and life sciences
3.2.2 Industry pitfalls & challenges
3.2.2.1 Biocompatibility and immunogenicity concerns
3.2.2.2 High cost associated with serum-free media
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.2.1 Microcarrier beads
5.2.1.1 Collagen coated beads
5.2.1.2 Cationic beads
5.2.1.3 Protein coated beads
5.2.1.4 Untreated beads
5.2.1.5 Other microcarrier beads
5.2.2 Media
5.2.2.1 Serum based media
5.2.2.2 Serum-free media
5.2.2.3 Other media
5.2.3 Reagents
5.2.4 Other consumables
5.3 Equipment
5.3.1 Bioreactor
5.3.1.1 Single-use bioreactor
5.3.1.2 Stainless steel bioreactor
5.3.2 Culture vessel
5.3.3 Cell counter
5.3.4 Filtration system
5.3.5 Other equipment
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Biopharmaceutical production
6.2.1 Vaccine production
6.2.2 Therapeutics production
6.3 Regenerative medicine
6.4 Other applications
Chapter 7 Market Estimates and Forecast, By End-User, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 CROs & CMOs
7.4 Academic & research institutes
7.5 Cell banks
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Bio-Rad Laboratories, Inc.
9.2 Corning Incorporated
9.3 Cytiva
9.4 denovoMATRIX GmbH
9.5 Eppendorf AG
9.6 Fujiform Holdings Corporation
9.7 Lonza Group AG
9.8 Merck KGaA
9.9 Sartorious AG
9.10 Thermo Fisher Scientific Inc.
